SNOA

Sonoma Pharmaceuticals, Inc.

SNOA | $0.1574 4.76% 150K

(0.0% 1d) (14.3% 1m) (-84.3% 1y) (0.0% 2d) (0.0% 3d) (-5.9% 7d) (-44.7% volume)
Earnings Calendar:
Market Cap: $ 2,456,610
http://www.sonomapharma.com
Sec Filling | Patents | 298 employees

(US) Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. The company offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Woodstock, GA.

dermatitis skin animals acne urea hypochlorous acid atopic dermatitis injection

Drugs

Deltasone (PredniSONE)
Doxycycline Hyclate (DOXYCYCLINE HYCLATE)
Mondoxyne NL (Doxycycline)

add to watch list Paper trade email alert is off

Press-releases

Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections
Published: 2024-04-04 (Crawled : 12:30) - biospace.com/
SNOA | $0.1574 4.76% 150K

Health Technology

| 1.27% | O: -6.39% H: 10.21% C: 8.18%
australia publication pharmaceuticals infections potential

Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences
Published: 2024-03-28 (Crawled : 22:00) - biospace.com/
SNOA | $0.1574 4.76% 150K

Health Technology

| -3.09% | O: -4.6% H: 21.84% C: 5.59%
pharmaceuticals research

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network
Published: 2024-01-09 (Crawled : 15:30) - biospace.com/
SNOA | $0.1574 4.76% 150K

Health Technology

| -10.66% | O: 2.18% H: 23.66% C: 0.55%
NBY | $0.077 6.21% 1.43% 1.6M

Health Technology

| -61.11% | O: 11.11% H: 19.4% C: -5.55%
pharmaceuticals network market

Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock
Published: 2023-10-26 (Crawled : 15:30) - biospace.com/
SNOA | $0.1574 4.76% 150K

Health Technology

| -56.85% | O: -50.11% H: 7.08% C: 0.54%
offering

Skyline Champion Announces Closing of the Acquisition of … – Business Wire
Published: 2023-10-13 (Crawled : 22:00) - spacfeed.com
NKLA | News | $0.6323 0.29% 0.28% 47M

Consumer Durables

| Email alert Add to watchlist
SNOA | $0.1574 4.76% 150K

Health Technology

| Email alert Add to watchlist
VSAC | $11.13 0.0% 24K

n/a

| Email alert Add to watchlist
LQR 4 | $0.995 4.63% 4.42% 72K